Russell Medford
Director/Board Member at THERMOGENESIS HOLDINGS, INC.
Net worth: - $ as of 2024-04-29
Profile
Russell M.
Medford was the founder of AtheroGenics, Inc. (founded in 1993) where he served as President, Chief Executive Officer & Director until 2009.
He is also the founder of Covanos, Inc. (founded in 2014) where he currently holds the position of Chairman & Chief Executive Officer.
Dr. Medford currently holds several positions including Chairman & President at Salutria Pharmaceuticals, Inc. (since 2009), Chairman at Atlantic Therapeutics Ltd.
(since 2022), Executive Chairman at Viamune, Inc. (since 2014), Chairman at OncoSpherix, Inc., Chairman at Global Center For Medical Innovation, Inc., and Independent Director at ThermoGenesis Holdings, Inc. (since 2017).
He is also a Director at Georgia Institute of Technology and Southeast BIO.
Additionally, he is the Managing Partner at Salutramed Group LLC (since 2012).
In his former roles, Dr. Medford served as Chief Executive Officer of Healthegames, Inc., Chairman of Center for Global Health Innovation, Inc., Vice Chairman of Georgia Global Health Alliance, Inc. (from 2016 to 2020), Chairman of Global Health Crisis Coordination Center, Chairman of Global Health ATL, Independent Director of Inhibitex LLC (from 1997 to 2012), and Director of Biotechnology Innovation Organization (from 2002 to 2014).
Dr. Medford's education includes an undergraduate degree from Cornell University, a doctorate degree from Yeshiva University, and a doctorate degree from Albert Einstein College of Medicine, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-30 | 0 ( -.--% ) | - $ | 2024-04-29 |
Russell Medford active positions
| Companies | Position | Start |
|---|---|---|
| THERMOGENESIS HOLDINGS, INC. | Director/Board Member | 2017-02-23 |
Atlantic Therapeutics Ltd.
 Atlantic Therapeutics Ltd. Medical SpecialtiesHealth Technology Atlantic Therapeutics Ltd. is a medical device developer of non-invasive pelvic floor strengthening and nerve stimulation products. The firm offers INNOVO products. The company is headquartered in Galway, Ireland. | Chairman | 2022-07-26 |
| OncoSpherix, Inc. | Chairman | - |
| Georgia Institute of Technology | Corporate Officer/Principal | - |
Covanos, Inc.
 Covanos, Inc. Packaged SoftwareTechnology Services Covanos, Inc. is an American medical technology company that has developed a technology platform combining advanced mathematical methods and computational fluid dynamics with clinical imaging to determine the functional significance of arterial blockages. The private company is based in Atlanta and was founded by Habib Samady. The company's first product, C-Heart, is a non-invasive, out-patient based, point-of-care, PC-based workstation solution that determines whether a patient with chest pain requires re-vascularization of a coronary artery blockage. Russell M. Medford has been the CEO of the company since 2014. | Chief Executive Officer | 2013-12-31 |
| Salutramed Group LLC | Corporate Officer/Principal | 2011-12-31 |
| Viamune, Inc. | Chairman | 2013-12-31 |
Salutria Pharmaceuticals, Inc.
 Salutria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Salutria Pharmaceuticals, Inc. operates drug stores. | Chairman | 2010-05-05 |
| Southeast BIO | Director/Board Member | - |
| ░░░░░░ ░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Former positions of Russell Medford
| Companies | Position | End |
|---|---|---|
| ░░░░░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ ░░░░░░ ░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
Training of Russell Medford
| Cornell University | Undergraduate Degree |
| Yeshiva University | Doctorate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| THERMOGENESIS HOLDINGS, INC. | Health Technology |
| Private companies | 15 |
|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Inhibitex LLC
 Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Healthegames, Inc.
 Healthegames, Inc. Miscellaneous Commercial ServicesCommercial Services Healthegames, Inc. provides public relations and communications services. The private company is based in Atlanta, GA. | Commercial Services |
Center for Global Health Innovation, Inc.
 Center for Global Health Innovation, Inc. BiotechnologyHealth Technology Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe. | Health Technology |
| Southeast BIO | |
Salutria Pharmaceuticals, Inc.
Salutria Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Salutria Pharmaceuticals, Inc. operates drug stores. | Retail Trade |
Global Center For Medical Innovation, Inc.
 Global Center For Medical Innovation, Inc. Medical SpecialtiesHealth Technology Global Center For Medical Innovation, Inc. provides medical devices. It provides medical device commercialization, innovation, prototyping, machine shop, cGMP manufacturing, preclinical testing, clinical trial, inovator education, regulatory assurance, quality assurance, 3D Printing-ProJet 6000, rapid prototyping, cleanroom. The company is headquartered in Atlanta, GA. | Health Technology |
Atlantic Therapeutics Ltd.
Atlantic Therapeutics Ltd. Medical SpecialtiesHealth Technology Atlantic Therapeutics Ltd. is a medical device developer of non-invasive pelvic floor strengthening and nerve stimulation products. The firm offers INNOVO products. The company is headquartered in Galway, Ireland. | Health Technology |
| Viamune, Inc. | |
| Georgia Global Health Alliance, Inc. | |
| Salutramed Group LLC | |
Covanos, Inc.
Covanos, Inc. Packaged SoftwareTechnology Services Covanos, Inc. is an American medical technology company that has developed a technology platform combining advanced mathematical methods and computational fluid dynamics with clinical imaging to determine the functional significance of arterial blockages. The private company is based in Atlanta and was founded by Habib Samady. The company's first product, C-Heart, is a non-invasive, out-patient based, point-of-care, PC-based workstation solution that determines whether a patient with chest pain requires re-vascularization of a coronary artery blockage. Russell M. Medford has been the CEO of the company since 2014. | Technology Services |
| OncoSpherix, Inc. | |
| Global Health Crisis Coordination Center |
- Stock Market
- Insiders
- Russell Medford
